BANK OF AMERICA CORP /DE/ - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 37 filers reported holding NOVELION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$1,000
-50.0%
1,296
-50.3%
0.00%
Q2 2019$2,0000.0%2,606
+79.5%
0.00%
Q1 2019$2,000
+100.0%
1,4520.0%0.00%
Q4 2018$1,000
-80.0%
1,452
-12.8%
0.00%
Q3 2018$5,000
-89.1%
1,665
-86.7%
0.00%
Q2 2018$46,000
+475.0%
12,522
+458.0%
0.00%
Q1 2018$8,000
-20.0%
2,244
-31.2%
0.00%
Q4 2017$10,000
-80.8%
3,263
-55.9%
0.00%
Q3 2017$52,000
-21.2%
7,402
+4.3%
0.00%
Q2 2017$66,000
-24.1%
7,097
-11.8%
0.00%
Q1 2017$87,000
+17.6%
8,047
-8.0%
0.00%
Q4 2016$74,0008,7500.00%
Other shareholders

There were no reported owners of NOVELION THERAPEUTICS INC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of NOVELION THERAPEUTICS INC shareholders